Passive immunotherapeutic strategies for the treatment of malignant gliomas.

Abstract

This review provides historical and recent perspectives related to passive immunotherapy for high-grade gliomas. The authors discuss approaches that use lymphokine-activated killer cells, cytotoxic T lymphocytes, and monoclonal antibodies. 
DOI: 10.1016/j.nec.2012.04.008

Topics

  • Presentations referencing similar topics